Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Nuvo Pharmaceuticals Inc. (T:NRI)

Business Focus: Pharmaceuticals

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for NRI within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Mar 24, 2020 08:30 ET
Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020
Life Sciences Investor Forum today announced the agenda for its inaugural event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and...
Read full article
Mar 23, 2020 10:00 ET
Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum March 26th
- Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com -
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
0.97
--
--
Price to Sales - TTM
0.09
3.05
7.06
Price to Book - most recent quarter
0.27
1.42
1.56
Price to Cash Flow per share - TTM
0.51
5.91
6.89
Price to Free Cash Flow per share - TTM
2.87
4.41
13.66
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Mar 15, 2020124,441-7,445
Feb 29, 2020131,8863,979
Feb 15, 2020127,907-5,245
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Nuvo Pharmaceuticals Inc, formerly Nuvo Research Inc, is a Canada-based healthcare company. The Company offers a range of commercial products, including Pennsaid 2%, Pennsaid and the heated lidocaine/tetracaine (HLT) patch. The Company's Pennsaid 2% is a non-steroidal anti-inflammatory drug (NSAID) containing 2% diclofenac sodium. Its Pennsaid 2% is indicated for treating the pain of osteoarthritis (OA) of the knee and also acute strains and sprains. The Company's Pennsaid is a topical pain product, which is used to treat the signs and symptoms of OA of the knee. The Pennsaid combines the transdermal carrier with diclofenac sodium, which is a NSAID and delivers the active drug through the skin at the site of pain. Its HLT Patch is a topical patch that combines lidocaine, tetracaine and heat, using Controlled Heat-Assisted Drug Delivery (CHADD) technology. HLT Patch provides local analgesia prior to painful needle procedures, such as dialysis, blood draws and pediatric needles.

See business summary

Twitter

Search (past week) for $NRI.CA

  • No tweets found